POLE and endometrial carcinoma: Since POLE-mutant endometrial carcinomas have been reported to have increased immunogenicity and to elicit intratumoral cytotoxic T cell infiltration [15–17], we performed immunohistochemical analysis of immune-related marker expression in tumor cells and tumor-infiltrating lymphocytes (TILs) using five cytotoxic T cell markers and immune checkpoint molecules.